Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive × dactolisib × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 2 Neuroectodermal Tumors, Primitive 1 Neoplasms 1 Glioblastoma 1 Brain Neoplasms 1

Interventions

Everolimus 2 pasireotide 1 gallium Ga 68 dotatate 1 fosbretabulin 1 entinostat 1 dactolisib 1 belzutifan 1 Surveys and Questionnaires 1 Photochemotherapy 1 Nivolumab 1 Fentanyl 1 Dihematoporphyrin Ether 1 90Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01628913 2016-04-07

Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors

Novartis

Phase 2 Terminated

62 enrolled 7 charts

Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡